Zydus Lifesciences Profit & Loss Annual
BSE: - | NSE: - | ISIN: - | Sector: -1,106.10 +18.65 (1.72%)Updated : 09 Jun 2026
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Operating Expense | 22,395.00 | 17,481.80 | 15,025.90 | 14,988.80 |
| Other Net | 509.50 | -63.50 | -32.70 | -0.70 |
| Diluted Weighted Average Shares | 100.62 | 100.62 | 101.19 | 101.56 |
| Depreciation/ Amortization | 1,408.00 | 915.80 | 764.10 | 722.70 |
| Operating Income | 4,753.40 | 5,759.70 | 4,521.50 | 2,248.60 |
| Net Income | 4,523.40 | 4,525.50 | 3,859.50 | 1,960.30 |
| Income Availableto Com Excl Extra Ord | 4,523.40 | 4,525.50 | 3,836.50 | 1,964.90 |
| Other Operating Expenses Total | 8,243.30 | 1,308.70 | 884.00 | 342.30 |
| Net Income Before Taxes | 6,104.50 | 6,026.70 | 4,808.90 | 2,589.70 |
| Minority Interest | -83.50 | -147.10 | -113.30 | -131.60 |
| Net Income After Taxes | 4,509.80 | 4,614.80 | 3,831.40 | 2,001.90 |
| Income Availableto Com Incl Extra Ord | 4,523.40 | 4,525.50 | 3,859.50 | 1,960.30 |
| Costof Revenue Total | 7,292.60 | 7,231.20 | 7,041.00 | 7,056.30 |
| Gross Profit | 19,855.80 | 16,010.30 | 12,506.40 | 10,181.10 |
| Interest Inc( Exp) Net- Non- Op Total | 841.60 | 296.00 | 303.20 | 321.00 |
| Unusual Expense( Income) | 1,033.20 | 219.60 | 17.70 | 604.20 |
| Diluted Net Income | 4,523.40 | 4,525.50 | 3,859.50 | 1,960.30 |
| DPS- Common Stock Primary Issue | 1.00 | 11.00 | 3.00 | 6.00 |
| Provisionfor Income Taxes | 1,594.70 | 1,411.90 | 977.50 | 587.80 |
| Equity In Affiliates | 97.10 | 57.80 | 118.40 | 94.60 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 4,523.40 | 4,525.50 | 3,836.50 | 1,964.90 |
| Total Revenue | 27,148.40 | 23,241.50 | 19,547.40 | 17,237.40 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 27,148.40 | 23,241.50 | 19,547.40 | 17,237.40 |
| Selling/ General/ Admin Expenses Total | 4,417.90 | 7,806.50 | 6,319.10 | 6,263.30 |
| Diluted Normalized EPS | 52.54 | 46.38 | 37.92 | 23.79 |
| Diluted EPS Excluding Extra Ord Items | 44.96 | 44.97 | 37.91 | 19.35 |
| Gain( Loss)on Saleof Assets | - | 34.50 | 16.90 | 20.80 |
| Total Extraordinary Items | - | 0.00 | 23.00 | -4.60 |
*All figures in crores except per share values
Zydus Lifesciences Quick Links
Zydus Lifesciences Dividend Zydus Lifesciences Bonus Zydus Lifesciences News Zydus Lifesciences AGM Zydus Lifesciences Rights Zydus Lifesciences Splits Zydus Lifesciences Board Meetings Zydus Lifesciences Key Metrics Zydus Lifesciences Shareholdings Zydus Lifesciences Balance Sheet Zydus Lifesciences Cashflow Zydus Lifesciences Q1 Results Zydus Lifesciences Q2 Results Zydus Lifesciences Q3 Results Zydus Lifesciences Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
386.70+13.70(3.67%)
1,460.05+25.20(1.76%)
250.80+3.05(1.23%)
4,239.20-59.90 (-1.39%)
2,278.00-29.75 (-1.29%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.